{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:16:32Z","timestamp":1758824192224},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,22]]},"DOI":"10.7759\/cureus.54667","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T09:14:47Z","timestamp":1708593287000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Astaxanthin in the Management of Oral Submucous Fibrosis: A Preliminary Randomized Controlled Trial"],"prefix":"10.7759","author":[{"given":"Elumalai","family":"Perumal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohmed Isaqali","family":"Karobari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000575","article-title":"A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis","volume":"29","author":"Phulari RG","year":"2020","unstructured":"Phulari RG, Dave EJ. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis. Eur J Cancer Prev. 2020, 29:470-3. 10.1097\/CEJ.0000000000000575","journal-title":"Eur J Cancer Prev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_522_17","article-title":"Oral submucous fibrosis: an enigmatic morpho-insight","volume":"15","author":"Hande AH","year":"2019","unstructured":"Hande AH, Chaudhary MS, Gawande MN, et al.. Oral submucous fibrosis: an enigmatic morpho-insight. J Cancer Res Ther. 2019, 15:463-9. 10.4103\/jcrt.JCRT_522_17","journal-title":"J Cancer Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47259","article-title":"Oral submucous fibrosis: a review of the current concepts in management","volume":"15","author":"Chhabra AK","year":"2023","unstructured":"Chhabra AK, Sune R, Reche A. Oral submucous fibrosis: a review of the current concepts in management. Cureus. 2023, 15:e47259. 10.7759\/cureus.47259","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_371_20","article-title":"Oral submucous fibrosis: an overview of a challenging entity","volume":"87","author":"Gupta S","year":"2021","unstructured":"Gupta S, Jawanda MK. Oral submucous fibrosis: an overview of a challenging entity. Indian J Dermatol Venereol Leprol. 2021, 87:768-77. 10.25259\/IJDVL_371_20","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6631856","article-title":"Research achievements of oral submucous fibrosis: progress and prospect","volume":"2021","author":"Xu H","year":"2021","unstructured":"Xu H, Lyu FY, Song JY, et al.. Research achievements of oral submucous fibrosis: progress and prospect. Biomed Res Int. 2021, 2021:6631856. 10.1155\/2021\/6631856","journal-title":"Biomed Res Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217167","article-title":"The role of astaxanthin as a nutraceutical in health and age-related conditions","volume":"27","author":"Bj\u00f8rklund G","year":"2022","unstructured":"Bj\u00f8rklund G, Gasmi A, Lenchyk L, et al.. The role of astaxanthin as a nutraceutical in health and age-related conditions. Molecules. 2022, 27:10.3390\/molecules27217167","journal-title":"Molecules"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu10040522","article-title":"Astaxanthin in skin health, repair, and disease: a comprehensive review","volume":"10","author":"Davinelli S","year":"2018","unstructured":"Davinelli S, Nielsen ME, Scapagnini G. Astaxanthin in skin health, repair, and disease: a comprehensive review. Nutrients. 2018, 10:10.3390\/nu10040522","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/md12010128","article-title":"Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review","volume":"12","author":"Ambati RR","year":"2014","unstructured":"Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review. Mar Drugs. 2014, 12:128-52. 10.3390\/md12010128","journal-title":"Mar Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106657","article-title":"Astaxanthin: a promising therapeutic agent for organ fibrosis","volume":"188","author":"Li K","year":"2023","unstructured":"Li K, Wang W, Xiao W. Astaxanthin: a promising therapeutic agent for organ fibrosis. Pharmacol Res. 2023, 188:106657. 10.1016\/j.phrs.2023.106657","journal-title":"Pharmacol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.138477.1","article-title":"A randomized interventional clinical trial assessing the safety and effectiveness of PeaNoc XL tablets in managing joint pain and inflammation in arthritis patients","volume":"12","author":"Kadanangode Narayanaswam N","year":"2023","unstructured":"Kadanangode Narayanaswam N, Caston E, Satish Kumar RC, Vijayakumar TM, Vanangamudi VS, Pankaj N, Sukkur A. A randomized interventional clinical trial assessing the safety and effectiveness of PeaNoc XL tablets in managing joint pain and inflammation in arthritis patients. F1000Res. 2023, 12:895. 10.12688\/f1000research.138477.1","journal-title":"F1000Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ccd.ccd_937_18","article-title":"Evaluation of efficacy of curcumin along with lycopene and piperine in the management of oral submucous fibrosis","volume":"10","author":"Mahato B","year":"2019","unstructured":"Mahato B, Prodhan C, Mandal S, et al.. Evaluation of efficacy of curcumin along with lycopene and piperine in the management of oral submucous fibrosis. Contemp Clin Dent. 2019, 10:531-41. 10.4103\/ccd.ccd_937_18","journal-title":"Contemp Clin Dent"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/md9030447","article-title":"Astaxanthin: a potential therapeutic agent in cardiovascular disease","volume":"9","author":"Fassett RG","year":"2011","unstructured":"Fassett RG, Coombes JS. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs. 2011, 9:447-65. 10.3390\/md9030447","journal-title":"Mar Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-7-18","article-title":"Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans","volume":"7","author":"Park JS","year":"2010","unstructured":"Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond). 2010, 7:18. 10.1186\/1743-7075-7-18","journal-title":"Nutr Metab (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng XM","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016, 12:325-38. 10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-016-0186-5","article-title":"The importance of antioxidants which play the role in cellular response against oxidative\/nitrosative stress: current state","volume":"15","author":"Kurutas EB","year":"2016","unstructured":"Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative\/nitrosative stress: current state. Nutr J. 2016, 15:71. 10.1186\/s12937-016-0186-5","journal-title":"Nutr J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104883","article-title":"Effects of antioxidants on oxidative stress and inflammatory responses of human bronchial epithelial cells exposed to particulate matter and cigarette smoke extract","volume":"67","author":"Son ES","year":"2020","unstructured":"Son ES, Park JW, Kim YJ, Jeong SH, Hong JH, Kim SH, Kyung SY. Effects of antioxidants on oxidative stress and inflammatory responses of human bronchial epithelial cells exposed to particulate matter and cigarette smoke extract. Toxicol In Vitro. 2020, 67:104883. 10.1016\/j.tiv.2020.104883","journal-title":"Toxicol In Vitro"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4783","article-title":"Antioxidant and anti\u2011inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review)","volume":"47","author":"Pereira CP","year":"2021","unstructured":"Pereira CP, Souza AC, Vasconcelos AR, Prado PS, Name JJ. Antioxidant and anti\u2011inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). Int J Mol Med. 2021, 47:37-48. 10.3892\/ijmm.2020.4783","journal-title":"Int J Mol Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/md10040890","article-title":"Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target","volume":"10","author":"Speranza L","year":"2012","unstructured":"Speranza L, Pesce M, Patruno A, Franceschelli S, Lutiis MA, Grilli A, Felaco M. Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar Drugs. 2012, 10:890-9. 10.3390\/md10040890","journal-title":"Mar Drugs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-023-00488-y","article-title":"Production and therapeutic use of astaxanthin in the nanotechnology era","volume":"75","author":"Abdelazim K","year":"2023","unstructured":"Abdelazim K, Ghit A, Assal D, et al.. Production and therapeutic use of astaxanthin in the nanotechnology era. Pharmacol Rep. 2023, 75:771-90. 10.1007\/s43440-023-00488-y","journal-title":"Pharmacol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/227395-efficacy-and-safety-of-astaxanthin-in-the-management-of-oral-submucous-fibrosis-a-preliminary-randomized-controlled-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T09:15:22Z","timestamp":1708593322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/227395-efficacy-and-safety-of-astaxanthin-in-the-management-of-oral-submucous-fibrosis-a-preliminary-randomized-controlled-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.54667","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}